These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 31399301)
1. SIRT6-mediated transcriptional suppression of MALAT1 is a key mechanism for endothelial to mesenchymal transition. Qin W; Zhang L; Li Z; Xiao D; Zhang Y; Yang H; Liu X; Zhang H; Chen X; Xu C; Yang B; Zhang Y Int J Cardiol; 2019 Nov; 295():7-13. PubMed ID: 31399301 [TBL] [Abstract][Full Text] [Related]
2. SIRT6 inhibits endothelial-to-mesenchymal transition through attenuating the vascular endothelial inflammatory response. Chen L; Wang G; He J; Yang X; Zheng Z; Deng Y; Liu Y; Chen D; Lin R; Wang W Int Immunopharmacol; 2021 Dec; 101(Pt B):108240. PubMed ID: 34666304 [TBL] [Abstract][Full Text] [Related]
3. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145. Xiang Y; Zhang Y; Tang Y; Li Q Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533 [TBL] [Abstract][Full Text] [Related]
4. LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway. Li H; Zhao Q; Chang L; Wei C; Bei H; Yin Y; Chen M; Wang H; Liang J; Wu Y Lipids Health Dis; 2019 Mar; 18(1):62. PubMed ID: 30871555 [TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG12 alleviates hypertensive vascular endothelial injury through miR-25-3p/SIRT6 pathway. Qian W; Zheng ZQ; Nie JG; Liu LJ; Meng XZ; Sun H; Xiao FM; Kang T J Leukoc Biol; 2021 Oct; 110(4):651-661. PubMed ID: 33464650 [TBL] [Abstract][Full Text] [Related]
6. SIRT6/LncRNA-MALAT1: A potential mechanism for treating aging-associated vascular diseases. He X; Ou C Int J Cardiol; 2020 Nov; 319():139. PubMed ID: 33012423 [No Abstract] [Full Text] [Related]
7. SIRT6 inhibits cholesterol crystal-induced vascular endothelial dysfunction via Nrf2 activation. Jin Z; Xiao Y; Yao F; Wang B; Zheng Z; Gao H; Lv X; Chen L; He Y; Wang W; Lin R Exp Cell Res; 2020 Feb; 387(1):111744. PubMed ID: 31759967 [TBL] [Abstract][Full Text] [Related]
8. SIRT6 protects against endothelial dysfunction and atherosclerosis in mice. Xu S; Yin M; Koroleva M; Mastrangelo MA; Zhang W; Bai P; Little PJ; Jin ZG Aging (Albany NY); 2016 May; 8(5):1064-82. PubMed ID: 27249230 [TBL] [Abstract][Full Text] [Related]
9. [Mechanism of long non-coding RNA-metastasis associated lung adenocarcinoma transcript 1 induced invasion and metastasis of esophageal cancer cell EC-109]. Zhang QQ; Cui YH; Wang Y; Kou WZ; Cao F; Cao XJ; Miao ZH; Kang XH Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):405-411. PubMed ID: 28635228 [No Abstract] [Full Text] [Related]
10. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Michalik KM; You X; Manavski Y; Doddaballapur A; Zörnig M; Braun T; John D; Ponomareva Y; Chen W; Uchida S; Boon RA; Dimmeler S Circ Res; 2014 Apr; 114(9):1389-97. PubMed ID: 24602777 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition. Sun R; Qin C; Jiang B; Fang S; Pan X; Peng L; Liu Z; Li W; Li Y; Li G Mol Biosyst; 2016 Mar; 12(3):952-62. PubMed ID: 26798987 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of β-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression. Sabbineni H; Verma A; Artham S; Anderson D; Amaka O; Liu F; Narayanan SP; Somanath PR Biochem Pharmacol; 2019 Jun; 164():205-215. PubMed ID: 30991049 [TBL] [Abstract][Full Text] [Related]
13. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter. Song S; Zhang R; Cao W; Fang G; Yu Y; Wan Y; Wang C; Li Y; Wang Q J Cell Physiol; 2019 Jun; 234(6):9052-9064. PubMed ID: 30378114 [TBL] [Abstract][Full Text] [Related]
14. Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis. Singh S; Adam M; Matkar PN; Bugyei-Twum A; Desjardins JF; Chen HH; Nguyen H; Bazinet H; Michels D; Liu Z; Mebrahtu E; Esene L; Joseph J; Ehsan M; Qadura M; Connelly KA; Leong-Poi H; Singh KK Sci Rep; 2020 Mar; 10(1):4466. PubMed ID: 32161282 [TBL] [Abstract][Full Text] [Related]
15. Sirtuin 6 inhibits MWCNTs-induced epithelial-mesenchymal transition in human bronchial epithelial cells via inactivating TGF-β1/Smad2 signaling pathway. Chen P; Tian K; Tu W; Zhang Q; Han L; Zhou X Toxicol Appl Pharmacol; 2019 Jul; 374():1-10. PubMed ID: 31005557 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis. Chen S; Wang G; Tao K; Cai K; Wu K; Ye L; Bai J; Yin Y; Wang J; Shuai X; Gao J; Pu J; Li H Cancer Sci; 2020 May; 111(5):1582-1595. PubMed ID: 32129914 [TBL] [Abstract][Full Text] [Related]
18. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis. Liu B; Qiang L; Wang GD; Duan Q; Liu J Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103 [TBL] [Abstract][Full Text] [Related]
19. Sirtuin 6 deficiency induces endothelial cell senescence via downregulation of forkhead box M1 expression. Lee OH; Woo YM; Moon S; Lee J; Park H; Jang H; Park YY; Bae SK; Park KH; Heo JH; Choi Y Aging (Albany NY); 2020 Nov; 12(21):20946-20967. PubMed ID: 33171439 [TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA MALAT1 Acts as a Competing Endogenous RNA to Regulate TGF- Dong N Biomed Res Int; 2019; 2019():1569638. PubMed ID: 31143769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]